Vontee is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Vonjil. The primary component is Silicon Dioxide; Sodium Pyrophosphate; Pyridoxine Hydrochloride; Sodium Fluoride.
Product ID | 80687-010_27b32b01-48cf-4892-8843-99689d5b4793 |
NDC | 80687-010 |
Product Type | Human Otc Drug |
Proprietary Name | Vontee |
Generic Name | Silicon Dioxide, Tetrasodium Pyrophosphate, Pyridoxine Hydrochloride, Sodium Flouride |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2020-10-01 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | VONJIL |
Substance Name | SILICON DIOXIDE; SODIUM PYROPHOSPHATE; PYRIDOXINE HYDROCHLORIDE; SODIUM FLUORIDE |
Active Ingredient Strength | 5 g/100g; g/100g; g/100g; g/100g |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-10-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VONTEE 90866101 not registered Live/Pending |
PARK, SANGYONG 2021-08-04 |